The government is likely to bear $6 to $7 per dose of millions of shots if it opts to pick the Oxford-AstraZeneca’s Covid-19 vaccine, which has been approved by the Drug Regulatory Authority of Pakistan (Drap). However, the vaccine’s sole authorised local distributor is at the moment unable to give a proper timeline for the supply.